Wedbush Upgrades bluebird bio (BLUE) to Outperform

November 4, 2019 6:12 AM EST
Get Alerts BLUE Hot Sheet
Price: $25.43 -0.9%

Rating Summary:
    14 Buy, 15 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten upgraded bluebird bio (NASDAQ: BLUE) from Neutral to Outperform with a price target of $124.00 (from $131.00).

For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.

Shares of bluebird bio closed at $82.86 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades